Epocrates Files for IPO

Epocrates Inc., a San Mateo, Calif.-based provider of clinical information and support tools to healthcare professionals, has filed for a $75 million IPO. It plans to trade on the Nasdaq under ticker symbol EPOC, with Citi serving as lead underwriter.

 

Shareholders include The Sprout Group (17% pre-IPO stake), Goldman Sachs (16%), InterWest Partners (12.7%), Draper Fisher Jurvetson (10.4%), Three Arch Partners (10.3%) and Bay City Capital (7.3%). www.epocrates.com